The DOI matches its Crossref record.
Renin- and Prorenin-Induced Effects in Rat Vascular Smooth Muscle Cells Overexpressing the Human (Pro)Renin Receptor: Does (Pro)Renin-(Pro)Renin Receptor Interaction Actually Occur?
Abstract
Renin/prorenin binding to the (pro)renin receptor ([P]RR) results in direct (angiotensin-independent) second-messenger activation in vitro, whereas in vivo studies in rodents overexpressing prorenin (≈400-fold) or the (P)RR do not support such activation. To solve this discrepancy, DNA synthesis, extracellular signal–regulated kinase 1/2 phosphorylation, and plasminogen-activator inhibitor 1 release were evaluated in wild-type and human (P)RR-overexpressing vascular smooth muscle cells after their incubation with 1 to 80 nmol/L of (pro)renin. Human prorenin (4 nmol/L, ie, ≈800-fold above normal) + angiotensinogen increased DNA synthesis in human (P)RR cells only in an angiotensin II type 1 receptor–dependent manner. Prorenin at this concentration also increased plasminogen-activator inhibitor 1 release via angiotensin. Prorenin alone at 4 nmol/L was without effect, but at 20 nmol/L (≈4000-fold above normal) it activated extracellular signal–regulated kinase 1/2 directly (ie, independent of angiotensin). Renin at concentrations of 1 nmol/L (≈2000-fold above normal) and higher directly stimulated DNA synthesis, extracellular signal–regulated kinase 1/2 phosphorylation, and plasminogen-activator inhibitor 1 release in wild-type and human (P)RR cells, and similar effects were seen for rat renin, indicating that they were mediated via the rat (P)RR. In conclusion, angiotensin generation depending on prorenin-(P)RR interaction may occur in transgenic rodents overexpressing prorenin several 100-fold. Direct (pro)renin-induced effects via the (P)RR require agonist concentrations that are far above the levels in wild-type and transgenic rats. Therefore, only prorenin (and not [P]RR) overexpression will result in an angiotensin-dependent phenotype, and direct renin-(P)RR interaction is unlikely to ever occur in nonrenin-synthesizing organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The (P)RR interacts with renin/prorenin at supraphysiological concentrations that are several orders of magnitude higher than (patho)physiological concentrations, questioning the physiological relevance of the (P)RR-(pro)renin interaction.
“The (pro)renin receptor ([P]RR) interacts with renin/prorenin (denoted as [pro]renin) at supraphysiological concentrations that are even several orders of magnitude higher than (patho)physiological concentrations, questioning the physiological relevance of the (P)RR–(pro)renin interaction.24,25”
From (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis (2018) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 33
- 10.1172/JCI0214276 · DOI
- 10.1038/sj.ki.5001627 · DOI
- 10.1161/01.hyp.0000199912.47657.04 · DOI
- 10.1097/HJH.0b013e3282f0ab66 · DOI
- 10.1161/hypertensionaha.109.138495 · DOI
- 10.1161/hypertensionaha.108.115444 · DOI
- 10.1161/hypertensionaha.107.101444 · DOI
- 10.1038/sj.ki.5002243 · DOI
- 10.1038/sj.ki.5000011 · DOI
- 10.1152/ajprenal.00119.2010 · DOI
- 10.1097/HJH.0b013e328343c62b · DOI
- 10.1161/hypertensionaha.109.128645 · DOI
- 10.1161/circresaha.110.224667 · DOI · Paper page
- 10.1126/science.1179802 · DOI · Paper page
- 10.1097/HJH.0b013e3282f05bae · DOI
- 10.1038/hr.2009.201 · DOI
- 10.1097/00004872-199816060-00017 · DOI
- 10.1074/jbc.M302579200 · DOI
- 10.1172/JCI21398 · DOI
- 10.2337/db08-0254 · DOI
- 10.1161/hypertensionaha.109.148221 · DOI
- 10.1161/hypertensionaha.110.169060 · DOI
- 10.1161/01.hyp.0000240064.19301.1b · DOI
- 10.1161/hy0202.103002 · DOI
- 10.1161/01.hyp.23.6.848 · DOI
- 10.1152/ajpheart.2001.280.4.H1706 · DOI
- 10.1161/01.HYP.29.6.1240 · DOI
- 10.1161/atvbaha.108.164210 · DOI
- 10.1373/clinchem.2008.118000 · DOI
- 10.1016/j.bbrc.2009.10.121 · DOI
- Biswas KB, Nabi AH, Arai Y, Nakagawa T, Ebihara A, Suzuki F . Species specificity of prorenin binding to the (pro)renin receptor in vitro. Front Biosci (Elite Ed). 2010;2:1234–1240.
- 10.1161/01.HYP.29.1.428 · DOI
- 10.1093/eurheartj/ehp012 · DOI
Cited by
Sorted by citations
Hypertension: Renin–Angiotensin–Aldosterone System Alterations
te Riet, L., van Esch, J. H. M., Roks, A. J. M., van den Meiracker, A. H., & Danser, A. H. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303587 · Cited by 706
Self-citationThe (pro)renin receptor in health and disease
Ichihara, A., & Yatabe, M. S. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0160-5 · Cited by 137
Ren, L., Sun, Y., Lu, H., Ye, D., Han, L., Wang, N., Daugherty, A., Li, F., Wang, M., Su, F., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312422 · Cited by 59
Self-citationIdentification of the (Pro)renin Receptor as a Novel Regulator of Low-Density Lipoprotein Metabolism
Lu, X., Meima, M. E., Nelson, J. K., Sorrentino, V., Loregger, A., Scheij, S., Dekkers, D. H. W., Mulder, M. T., Demmers, J. A. A., M-Dallinga-Thie, G., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.306799 · Cited by 48
Self-citation
Metadata
- Authors
- Batenburg, W. W., Lu, X., Leijten, F., Maschke, U., Müller, D. N., & Danser, A. H. J.
- Affiliations
- From the Division of Pharmacology and Vascular Medicine (W.W.B., X.L., F.L., A.H.J.D.), Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands; Max Delbrück Center for Molecular Medicine (U.M., D.N.M.), Berlin, Germany; Department of Experimental Medicine (D.N.M.), University of Erlangen-Nürnberg, Erlangen, Germany.
- Venue
- Hypertension
- Published
- 2011-12
- Volume
- 58
- Issue
- 6
- Pages
- 1111-1119
- ISSN
- 0194-911X
- 1524-4563
- Cited by
- 59
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review